Acute gastric pH changes alter intraluminal but not plasma peptide levels.
Gastric acidity is influenced by systemic and local peptide effects. Previous work by others has shown that intraluminally secreted peptides may have a role in local control of gastric acidity; however, the response of these peptides to acute changes in gastric pH is unknown. To determine the effects of acute changes in pH on systemic and intraluminal peptide levels, 14 normal volunteers underwent placement of a nasogastric tube after an overnight fast. Blood and gastric fluid were analyzed on a control day, 2 hours after completion of 24 hours of aluminum-magnesium antacid therapy and after 24 hours of H2 blockade. Plasma and acid-alcohol-extracted gastric peptide levels were measured with specific radioimmunoassays. Specimens were subdivided into two groups: 28 gastric fluid specimens with a pH less than 4 and 10 specimens with a pH greater than 4. In the patients with a pH greater than 4, the luminal peptides, motilin, neurotensin, pancreatic polypeptide, somatostatin, substance P, and gastrin, were decreased by 50% to 90% and gastrin-releasing peptide was decreased by 36% compared with specimens with a pH less than 4. Conversely, intraluminal vasoactive intestinal polypeptide and calcitonin levels were elevated by 60% and 27%, respectively, in the samples with a pH greater than 4. Intraluminal peptide concentrations are responsive to changes in intragastric pH; however, this response was not seen in plasma peptide levels.
Mueller
C R
CR
Department of Surgery, Oregon Health Sciences University, Portland.
Ure
T
T
O'Dorisio
T M
TM
Barrie
R J
RJ
Woltering
E A
EA
D000863:Antacids / Q000494:pharmacology; D002116:Calcitonin / Q000378:metabolism; D005260:Female; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism*; D019886:Gastrin-Releasing Peptide; D005755:Gastrins / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D009037:Motilin / Q000378:metabolism; D009496:Neurotensin / Q000378:metabolism; D015282:Octreotide / Q000494:pharmacology; D010191:Pancreatic Polypeptide / Q000378:metabolism; D010455:Peptides / Q000378:metabolism*; D011899:Ranitidine / Q000494:pharmacology; D013004:Somatostatin / Q000378:metabolism; D013373:Substance P / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism
D000863:Antacids; D005755:Gastrins; D010455:Peptides; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D009496:Neurotensin; D013004:Somatostatin; D009037:Motilin; D010191:Pancreatic Polypeptide; D019886:Gastrin-Releasing Peptide; D011899:Ranitidine; D002116:Calcitonin; D015282:Octreotide